Citation

80 FR 15226

Multiple canonical documents share this first-page citation.

National Cancer Institute; Notice of Closed Meetings Monday, March 23, 2015 80 FR 15226
Prospective Grant of Start-up Exclusive Evaluation Option License Agreement: Pre-Clinical Evaluation and Commercial Development of Anti-Tyrosine Kinase-Like Orphan Receptor 1 Antibody-Drug Conjugates for the Treatment of Human Cancers Monday, March 23, 2015 80 FR 15226